Cargando…
Polycystic kidney diseases: From molecular discoveries to targeted therapeutic strategies
Polycystic kidney diseases (PKDs) represent a large group of progressive renal disorders characterized by the development of renal cysts leading to end-stage renal disease. Enormous strides have been made in understanding the pathogenesis of PKDs and the development of new therapies. Studies of auto...
Autores principales: | Ibraghimov-Beskrovnaya, O., Bukanov, N. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Birkhäuser-Verlag
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2775119/ https://www.ncbi.nlm.nih.gov/pubmed/17975706 http://dx.doi.org/10.1007/s00018-007-7362-x |
Ejemplares similares
-
Differences in the timing and magnitude of Pkd1 gene deletion determine the severity of polycystic kidney disease in an orthologous mouse model of ADPKD
por: Rogers, Kelly A., et al.
Publicado: (2016) -
Loss of GM3 synthase gene, but not sphingosine kinase 1, is protective against murine nephronophthisis-related polycystic kidney disease
por: Natoli, Thomas A., et al.
Publicado: (2012) -
Reduction of ciliary length through pharmacologic or genetic inhibition of CDK5 attenuates polycystic kidney disease in a model of nephronophthisis
por: Husson, Hervé, et al.
Publicado: (2016) -
Beyond polycystic kidney disease
por: Santos, Susana Franco, et al.
Publicado: (2017) -
CDK inhibitors R-roscovitine and S-CR8 effectively block renal and hepatic cystogenesis in an orthologous model of ADPKD
por: Bukanov, Nikolay O., et al.
Publicado: (2012)